JPMorgan, Wells Fargo and Leerink are acting as joint book running managers for the offering. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on NPCE: NeuroPace announces $65M common stock offering NeuroPace price target raised to $17 from $13 at Wells Fargo NeuroPace price target raised to $19 from $18 at Cantor Fitzgerald NeuroPace Projects 2025 Growth and Product Enhancements NeuroPace sees FY25 revenue $92M-$96M, consensus $91.23M Disclaimer & DisclosureReport an Issue
